Abstract
To the Editor. —I was excited to read the article by Pastuszak et al1reporting on a prospective study of 128 women who took therapeutic doses of fluoxetine during their first trimester of pregnancy compared with the pregnancy outcome of two matched groups of women exposed to either nonteratogens or tricyclic antidepressants. Rates of major congenital malformations were similar for the three groups. This prospective study follows close on the heels of two studies reported inLancetin 1992. Jacobson et al2reported in a prospective study the pregnancy outcome after lithium exposure during the first trimester of pregnancy, and Bergman et al3published the results of a study of exposure to benzodiazepines during fetal life using a retrospective approach. In the first study,2women taking an average of 927 mg of lithium were compared with a control group of pregnant women who were taking drugs
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
